TNAP, TrAP, ecto-purinergic signaling, and bone remodeling

Bone remodeling involves resorption by osteoclasts and formation by osteoblasts. The bone multicellular unit includes osteocytes, osteoblasts, and osteoclasts. The bone remodeling compartment is isolated from marrow by lining cells. Cytokine and hormonal regulation of bone remodeling is well studied. Less is known about extracellular pH's role in this process. Osteoclasts function in acidic environments. Their structure resembles epithelial cells, forming a seal against bone. Acid and alkaline phosphatases are major ecto-phosphatases in bone cells. These enzymes have ATPase activity with pH optima far from neutral.

This study aims to explore the role of extracellular pH in bone remodeling. The focus is on ecto-phosphatases and purinergic signaling. The authors seek to understand how pH(e) influences osteoclast and osteoblast activity. They hypothesize that ecto-phosphatases regulate ATP and pH(e) at resorption and mineralization sites. The study reviews data on BRC pH(e) regulation. It proposes a hypothesis about pH regulation in bone compartments. The authors aim to contextualize this hypothesis within known pH-regulating proteins. The goal is to clarify how pH(e) affects bone cell function.

The authors conducted a literature review of pH(e) regulation in bone compartments. They analyzed the function of ecto-phosphatases in ATP hydrolysis. They examined the role of P2 receptors in osteoclast and osteoblast activity. The study considered the effect of HCO3(-) on BRC pH(e). The authors evaluated how pH(e) influences bone cell behavior. They synthesized findings from prior studies on bone remodeling. The methods included reviewing existing data on pH(e) and ATP interactions. The authors proposed a hypothesis based on these findings.

Osteoclasts and osteoblasts express P2 receptors that respond to ATP. Acid and alkaline phosphatases have ATPase activity with pH optima far from neutral. These enzymes may regulate ATP and pH(e) at resorption and mineralization sites. Osteoclasts secrete HCO3(-) into the BRC, which may elevate pH(e). This pH change could affect osteoblast function. The authors suggest that pH(e) regulation is linked to ATP hydrolysis and P2Y signaling. The data support a model where pH(e) influences bone cell activity. The findings highlight the importance of pH(e) in bone remodeling.

The authors propose that ecto-phosphatases regulate ATP and pH(e) at bone remodeling sites. They suggest that pH(e) changes influence osteoblast and osteoclast function. The study emphasizes the role of P2 receptors in bone cell signaling. The findings indicate that pH(e) is a key factor in bone remodeling. The authors suggest that HCO3(-) secretion affects BRC pH(e). These conclusions are based on existing data and proposed mechanisms. The study does not suggest new drug targets or future directions. The authors summarize the evidence supporting pH(e) regulation in bone remodeling.